This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Atrial Fibrillation
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Non-vitamin K oral anticoagulants (NOAC) have been shown to be safe and effective alternatives to warfarin for stroke prevention in patients with nonvalvular AF (NVAF). There are yet limited real life data on outcomes following elective cardioversion in AF patients treated with NOACs. The aim of this study is to investigate the complications and the use of NOACs in AF patients undergoing cardioversion.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02911545. The sponsor of the trial is Helsinki University Central hospital and it is looking for 1000 volunteers for the current phase.
Official trial title:
Non-vitamin K Oral Anticoagulants in Cardioversion of Atrial Fibrillation. FinCV3